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Patterns of DNA methylation in complex genomcs like those of mammalian cells have been viewed as indicators of different levels of genetic activi- 
ties. It is as yet unknown how these complicated patterns are generated and mamtained during cell replication. There is evidence from many different 
biological systems that the sequence-specific methylation of promoters in htgher eukaryotes is one of the important factors in controlling gene 
activity at a long-term level. In general. the fifth nucleotide 5-methyldeoxycytidine can be considered as a modulator of protein-DNA interactions. 
The degree and directron of this modulation has to be assessed experimentally in each individual instance. The establishment of de novo patterns 
of DNA methylatton is characterized by the gradual non-random spreading of DNA methylation by an essentially unknown mechanism. In this 
review, some of the general concepts of DNA methylation in mammalian systems are presented, and research currently performed in the authors’ 
laboratory has been summarized. 
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1. INTRODUCTION 
In the five letter genetic text, the embellishment by a 
fifth nucleotide, 5methyldeoxycytidine (5mC), 
generates specific patterns in eukaryotic DNA. While 
we begin to decipher the ways in which the presence of 
S-mC in a sequence motif affects or fails to influence 
detectably the interaction with a specific protein, the 
biological significance of apparently highly specific and 
rather stable patterns of DNA methylation is still 
unknown. The genetic signal 5-mC can be considered as 
a modulator of DNA-protein interactions. The direc- 
tion of this interaction cannot be predicted but has to be 
determined experimentally. Frequently, the interaction 
of a specific protein with a sequence motif is abrogated 
by 5-mC, e.g. in motifs in the E2A promoter of 
adenovirus DNA [ 1,2]. In other motifs, e.g. SPl, 5-mC 
does not interfere detectably with the binding of this 
transcription factor [3,4]. On the other hand, there are 
mammalian proteins which bind specifically to 
methylated DNA sequences [5,6]. Lastly, several 
restriction endonucleases from prokaryotes, e.g. DpnI 
(Diplococcus pneumoniae), NmuDI, NmuEI (Neisseria 
Correspondence address: W. Doerfler, lnstitut ftir Genetik, Univer- 
ritat zu Kdln, Weyertal 121, D-5000 Koln 41, FRG 
*Presenr uddress: Department of Molecular Biology, Princeton 
University, Princeton, NJ 08544-1014, USA 
mucosa) [7] require for activity the presence of a 
methylated nucleotide, in these cases N6-methyl- 
deoxadenosine (N6-mA) in the recognition sequence 
5 ‘-GCAT-3’. It is conceivable that the presence of a 
methylated nucleotide in a DNA sequence alters locally 
the structure of the DNA double helix. Definite infor- 
mation is not available on this problem. 
In eukaryotic systems, the most extensively studied 
and best-documented effect of DNA methylation on a 
specific biological function is the inhibition or inactiva- 
tion of promoters by sequence-specific methylation (for 
reviews, see [8-l 11). Via promoter inactivation, DNA 
methylation obviously could interfere with many highly 
complex biological phenomena. Effects on differentia- 
tion, oncogenesis, parental imprinting [12], the inac- 
tivation of the X-chromosome [13], and others have 
been invoked in this context. 
Obviously, many additional mechanisms, e.g. DNA 
replication, recombination, repair, and DNA structure 
need to be investigated for possible modulating effects 
of sequence-specific DNA methylations. So far, we 
have only a limited understanding of the influence of a 
few isolated .5-mC residues in eukaryotic (mammalian) 
DNA on biochemical reactions involving DNA-protein 
interactions. In mammalian DNA complex patterns of 
DNA methylation have been described (e.g. [14,151), 
but the problem of ‘pattern recognition’ remains to be 
studied. Such patterns are likely to affect a host of dif- 
ferent DNA-protein interactions, and in that way might 
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alter structure and functions of entire domains of 
DNA. 
2. BASIC FINDINGS ON DNA METHYLAT~ON 
In the DNA of higher eukaryotes, in particular of 
mammals, 5-mC appears to be the only modified 
nucleotide. The occurrence of N6-mA in mammalian 
DNA is unlikely, but cannot be rigorously excluded. It 
is thought that the modified nucleotide 5-mC abounds 
in the nucleotide combinations 5’-CG-3’ or perhaps 
5 ’ CXG-3 ’ , but the other dinucleotide combinations, 
5 ’ -CA-3 ’ ,5 ’ -CC-3 ’ , or 5 ’ -CT-3 ’ , have also been iden- 
tified as sites for S-mC. There is evidence that in human 
DNA the presumably atypical d~nucleotide combina- 
tions may contain an unexpectedly high proportion of 
5-mC [ 161. It has been recognized that 5’ CC-3 
dinucleotides are frequently clustered in the 5’-region 
of eukaryotic genes [ 17,181. In fact, so-called CG- 
islands have been described in the 5’-regions of many 
polymerase II-transcribed genes [19,20]. It is thought 
that the methylation of certain 5 ’ -CC-3 ’ dinucleotides 
in the 5’-region of genes contributes to the long-term 
silencing of these genes [8- 111. 
A given pattern of DNA methylation is preserved, in- 
herited as it were, by the enzymatic mechanism of 
maintenance methylation. Postreplicationally, certain 
cytidine (C) residues are methylated by the enzyme 
DNA methyhransferase which uses S-adenosylmethio- 
nine as the methyl donor. For the sequences 5’-CG-3’ 
or 5 ‘-CXG-3’ the parental strand, which remains 
methylated after DNA replication, can serve as the 
memory strand for the DNA methyltransferase to im- 
pose symmetrically methyl groups on the newly syn- 
thesized, hence not yet methylated, DNA compiement. 
More complicated controlling elements seem to be 
operative in the process of maintenance methylation, 
because, at least in continuous cell lines in culture, 
hemimethylated DNA sequences have been observed 
over several cel1 generations [21-231. Apparently, 
lnaintenance methyiation can be delayed after DNA 
replication. 
The gene for at least one mammalian DNA 
methyltransferase has been cloned from mouse cells, 
and its nucleotide sequence has been determined [24]. 
The nucleotide sequence reveals a DNA-binding do- 
main in the DNA methyltransferase gene and a second 
domain responsible for the methyl transfer. This latter 
domain has a high degree of homology [24] to a consen- 
sus sequence for many of the prokaryotic DNA 
methyltransferases [25]. The cloned gene for the mam- 
malian DNA methyltransferase is of low abundance 
and there are no apparent homologies to other parts of 
the mammalian genome. This finding together with the 
high degree of similarity to the consensus sequence for 
prokaryotic DNA methyltransferases has prompted the 
idea that there might be only one such enzyme in mam- 
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malian cells. This proposal deserves critical evaluation. 
It is also conceivable that additional factors are essen- 
tial for the regulation and/or specificity of the mam- 
malian DNA methyltransferase. 
Formally, one can distinguish a second type of DNA 
methylation, that of de novo methylation. An example 
studied in this laboratory may serve to illustrate this 
point. The DNA in the adenovirus particle is not detec- 
tably methylated, nor is free intranuclear DNA 
replicating or persisting in infected cells 126,271. The 
viral DNA can become integrated into the genome of 
mammalian cells by covalent phosphodiester bonds 
[28-301. The integrated viral DNA eventually becomes 
de novo methylated in highly specific patterns [29], 
such that the early viral genes, w>hich are expressed in 
adenovirus-transformed cells, are undermethylated. 
The late, silenced viral genes are, however, strongly 
methylated [ 14,151. This inverse correlation between 
DNA methylation and levels of gene expression provid- 
ed at the time one of the first examples for an involve- 
ment of DNA methylation in the regulation of gene es- 
pression. Many cell generations in culture are required 
for these specific patterns of methylation to become 
established after the integration of the viral genome 
([31], G. Orend, I. KuhIman and W. Doerfler, 
manuscript in preparation). It is one of the unresolved 
problems to understand how de novo patterns of 
methylation arise and what enzymes and cofactors are 
involved in generating these patterns. In a practicai 
sense, this phenomenon is of importance in that very 
frequently genes that are added to an existing genome, 
e.g. in transfection and transgenic animal experiments, 
become rapidly inactivated, presumably as a conse- 
quence of highly specific de novo methylation. 
There is evidence that segments of DNA can become 
demethylated in the absence of concomitant DNA 
replication [23,32]. The enzymatic mechanism for this 
direct demethylation has not yet been elucidated. Ap- 
parently, this demethylation can be transient and 
restricted to only one DNA complement. Demethyla- 
tion seems to precede the reactivation of the correspon- 
ding promoter and gene sequences. It is as yet 
unknown, whether the demethylation of one strand suf- 
fices in all cases for gene reactivation to occur. There is 
evidence for one of the adenovirus promoters that 
hemimetilylation of the promoter in either complement 
leads to promoter inactivation (121, U. Freisem-Rabien, 
and W. Doerfler, manuscript in preparation), but there 
may be differences from promoter to promoter depen- 
ding, e.g. on whether hemimethylation alone can in- 
terfere with the binding of an essentia1 transcription 
factor. 
3. TECHNIQUES USED FOR THE ANALYSIS OF 
DNA METHYLATION 
The first investigations on DNA nlethylation 1331 
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relied on the chemical characterization of the modified 
nucleotide. In later years, 5-mC has been identified and 
quantitated in total hydrolysates of DNA by a combina- 
tion of chromatographic and electrophoretic pro- 
cedures (e.g. [26,34, 351). The recognition of genetically 
relevant patterns of DNA methylation in specific 
segments of a genome has become possible after the 
detection of methylation-sensitive restriction en- 
donucleases (review in [7]). An important role in this 
respect was played by the discovery of the 
isoschizomeric restriction endonuclease pair IipaII 
(Haemophilus parainfluenzae) and MspI (Moraxelia 
species) [36]. HpaII cannot cleave the sequence 
5 ’ -CCGG-3 ’ when the 3 ‘-located C residue is 
methylated or hemimethylated, but cuts the 
unmethylated sequence. MspI is blocked only when the 
5’ -located C is modified. Thus, methylated or 
unmethylated 5 ’ -CCGG-3 ’ sequences can be 
distinguished by differential cleavage of the same DNA 
with these two enzymes. Of course, a sequence like 
5’-CCGG-3’ comprises only lo-15% of all the 
5 ‘-CG-3’ dinucleotide combinations in a sequence that 
might become methylated. Therefore, the results of a 
restriction analysis of DNA methylation are necessarily 
limited. The method of genomic sequencing 1371 allows 
the determination of all the 5-mC residues in a 
nucleotide sequence. This method is based on the 
failure of hydrazine to modify 5-mC, and thus 
piperidine cannot cleave at the position of 5-mC, 
whereas the C reactions can proceed normally. Hence, 
the presence of 5-mC causes an interruption, a missing 
rung, in a sequencing ladder. The existence of a 
presumptive 5-mC residue in a sequence must be 
verified by the demonstration of a G residue in the com- 
plementary position of the opposite strand to exclude 
the possibility of a mutation. 
4. SEQUENCE-SPECIFIC METHYLATION CAN 
CAUSE PROMOTER INACTIVATION 
This topic has been extensively reviewed in the past 
(e.g. [S-l 1,381; contributions in [39]). A summary of 
the adduced experimental evidence will be presented. In 
this laboratory, we have used the promoter of the ElA 
gene of adenovirus type 12 (Ad12) [40] and the late pro- 
moter of the E2A gene of adenovirus type 2 (Ad2) 
[41-431 to demonstrate the inactivation of promoters by 
sequence-specific promoter methylations. The late E2A 
promoter was methylated in vitro in positions - 215, 
+ 6, and +24 by the HpaII DNA methyitransferase 
(.5’-CCGG-3’). Promoter inactivation was assessed in 
transient microinjection (oocytes of Xenopus laevis) or 
transfection experiments (mammalian cells) [42,43]. 
The same promoter as a fusion construct with an in- 
dicator gene was integrated into the genome of mam- 
malian cells, and the inactivation by methylation was 
documented also in this system [44]. Lastly, an in vitro 
transcription system was used to demonstrate the in- 
hibition of the late E2A promoter by 5’-CCGG-3’ 
methylation at the three aforementioned sequences 
[45]. The promoter sequences, the methylation of which 
led to promotor inactivation, were originally iden- 
tified by studying inverse correlations between pro- 
moter methylation and gene inactivation in Ad12-or 
AdZ-transformed cell lines [ 14,15,45a]. These data 
taken together have led to the conclusion that sequence- 
specific promoter methylation can cause promoter inac- 
tivation. The decisive sites in any promoter have ap- 
parently to be elucidated experimentally, since their 
locations in the promoter and upstream or downstream 
sequences cannot be predicted. For the late E2A pro- 
moter, it has been demonstrated that the methylation of 
the + 6 and + 24 cytidine residues abrogates the binding 
of specific protein(s) to these downstream sequences 
[2], even when these sequences are only heminlethyl- 
ated. In other parts of that promoter, methylated 
nucleotides interfere with the binding of proteins in 
certain regions, but not in others [22]. 
5. REVERSAL OF THE INACTIVATION 
Promoter inactivation by sequence-specific methyla- 
tion is not unconditional, but can be reversed by trans- 
activation [43,46,47] or by a strong viral enhancer [48]. 
At least partial reactivation has been effected by the 289 
amino acid protein encoded in the ElA region of the 
adenovirus genome. The methylated E2A promoter can 
be located both in the cellular genome or ex- 
trachromosomally in a plasmid construct and can be 
reactivated by the viral transactivator gene either in the 
chromosomal or extrachromosomal localization 
[47,49]. Reactivation is not accompanied by changes in 
the status of methylation in the reactivated E2A pro- 
moter, at least not in both DNA strands. EIA transac- 
tivation is thought to operate via protein-protein in- 
teractions [50]. This mechanism has, however, not yet 
been proven for the reactivation of a methylated and 
reactivated promoter. Since foreign genes artificially 
added to an existing genome frequently become inac- 
tivated by methylation, it would be sensible, for prac- 
tical purposes, to introduce these foreign genes jointly 
with a transactivator gene or with a strong enhancer in 
order to counteract the inactivation due to methylation. 
6. THE SPREADING OF DNA METHYLATION 
AND THE ESTABLISHMENT OF DE NOVO 
PATTERNS OF DNA METHYLATION 
Foreign DNA inserted into an established mam- 
malian genome becomes methylated in specific pat- 
terns. We have studied this phenomenon with Ad12 
DNA integrated into the genome of hamster tumor 
cells. The previously unmethylated viral DNA is 
methylated in specific patterns in the course of several, 
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sometimes many, cell generations [31]. In colinearly in- 
serted viral DNA, methylation is often initiated in the 
central part of the integrated foreign genome, and the 
terminal sequences abutting the cellular DNA are 
methylated much later or not at all (G. Orend, I. 
Kuhlmann, and W’. Doerfler, manuscript in prepara- 
tion). On the other hand, viral DNA replicating or per- 
sisting in the nucleus of mammalian cells in the non- 
integrated form is not detectably methylated. 
Moreover, human cellular DNA sequences, which are 
highly methylated in the cellular genome, remain 
unmethylated when the same cellular sequences are in- 
tegrated as part of the genome of a viral-cellular sym- 
metric recombinant (SYREC) and replicate in the 
nucleus of the same human cells in the non-integrated 
form [5 I]. Hence, chromosomal localization and 
organization may be important prerequisites fat 
specific patterns of DNA methylation to arise, 
Nucleotide sequence alone does not seem to be the 
determining factor. 
In foreign DNA that has been methylated in vitro in 
a few C residues and has s~~bseq~lerltly become in- 
tegrated into mammalian DNA, a gradual spreading of 
DNA methylation has been observed until eventually an 
entire region of the viral genome is completely 
methylated in all 5’-CG-3’ sequences 121,221. This 
spreading effect may involve even non-5 ’ -CG-3 ’ 
djnucleotides. The spreading of DNA methylation ap- 
pears to be an essential element in the establish~~lcIlt of 
de novo patterns of DNA methylation. The spreading 
seems to proceed in a non-contiguous manner in that 
DNA segments bound to protein are initially excluded 
from the immediate spreading process and are 
methylated only at a later stage. As a consequence, the 
binding of many of the proteins is obliterated in the 
completely methylated region. These conclusions have 
been derived from genomic sequencing and footprin- 
ting experiments [21,22]. The spreading of DNA 
methylation may explain the programmed inactivation 
of genes in development and on one of the X- 
chromosomes [ 131. 
The problem has been discussed whether DNA 
methylation was cause or consequence of promoter in- 
activation. In a sense, both considerations can apply. 
The introduction of one or a few 5-mC groups into 
decisive sequences in a regulatory region of a gene 
causes promoter inactivation. This initially very limited 
level of promoter methylation will probably escape 
detection by restriction analyses. The spreading of 
DNA methyIation in this segment is initiated by the few 
S-mC residues 121,221 and will successively lead to rhe 
complete methylation of the promoter and the 
neighboring sequences. At this extent of DNA methyla- 
tion, it will be demonstrable by cleavage with ap- 
propriate restriction endonucleases. Now, it appears 
that DNA methylation may be the consequence of pro- 
moter inactivation. This interpretation is only partly 
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correct, because it failed to consider the few 5-mC 
groups that initially caused promoter inactivation but 
were not detected by the limited technology. 
7. METHYLATION PATTERNS IN HUhlilrN DNA 
As a working hypothesis, it is proposed that the pat- 
terns of methylation in an entire genome reflect the 
states of activity in that penome. Presumably, states ot 
activity and patterns in the distrib~ltioI1 of I~e~hylat~d 
nucleotides differ depending on cell type or tissue. It is, 
therefore, the goal of our research to determine these 
patterns in selected areas of the human genomr. Since 
cell lines represent a highly selected pop~lIatio~i of cells 
with cell line-specific patterns of gene acti\+ty and DNA 
methylation, it is mandatory to determine these pat- 
terns directly in primary human cells. Human lym- 
phocytes and granulocytes are easily available as 
sources for human DNA, Two techniques have been 
chosen for the analysis. On the one hand, the 
5 ’ -upstream and pronlot~r regions of the human genes 
for tumor necrosis factors UI and $ ha\:e been analyzed 
by the genomic sequencing technique to localize all 
S-mC residues in these sequences. A surprisingly high 
concordance in the distribution of S-mC groups among 
different individuals, even of different ethnic origins, 
has been obser\:ed [52]. In other experiments, larger 
segments of the human genome have been screened for 
their methylation patterns by the more conventional 
HpuII-Mspl restriction analysis. As hybridization pro- 
bes, randomly selected cosmid clones of human DNA 
with a low content of repetitive DNA sequences have 
been utilized. Even with that less sensitive analytical ap- 
proach, that allows a survey of larger segments of the 
genome, very similar, if not identical, patterns have 
been revealed in different individuals {A. Behn-Krappa, 
I. Hoelker and W. Docrfler, manuscript in prepara- 
tion). On the other hand, when human cell lines of Iym- 
phatic, leukemic or Iymphoma origin ha\r been in- 
\,estigated for rnethylation patterns, a remarkable 
heterogeneity has been found (S. ,4chten, A. Behn- 
Krappa, D. Heuss, B. Schmitz, M. Jiicker, H. Tesch, 
V. Diehl and W’. Doerfler, manuscript in preparation). 
It is apparent that cell lines will not constitute the cell 
type of choice for investigations on methylation pat- 
terns in the human genome. 
In a cell, information about patterns of DNIS, 
methylation in many segments of the genome might 
allow one to interpret the state of genetic activity. Of 
course, we are far from even a vague comprehension of 
genetic activity levels in different human cell types. 
Would the detcrrnination of patterns of methylation 
provide one tool for obtaining an improved insight into 
the genetic ac:ivities, and probably not only of 
transcriptional activities, in different segments of the 
human genome? 
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